# Polyarthritis

> A 30-year-old female presented with polyarthralgia for 2 months duration. Discuss the
> differential diagnosis.

## Possible Diagnoses (Most to least likely)

1. **Rheumatoid arthritis (RA)**
2. **Systemic lupus erythematosus (SLE)**
3. **Post-viral arthritis** (e.g., Chikungunya, Hepatitis B/C, Parvovirus B19)
4. **Psoriatic arthritis**
5. **Reactive arthritis** (post-enteric or post-urethritis)

## Clinical Features of Each Diagnosis

| Diagnosis                                 | Key Clinical Features                                                                                                                                                                                                       |
| ----------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **1. Rheumatoid arthritis (RA)**          | - Symmetrical small joint pain (MCP, PIP) > large joints<br/>- Morning stiffness >1 hr, improves with use<brr/>- Joint swelling, tenderness, warmth<br/>- Extra-articular: nodules, episcleritis, interstitial lung disease |
| **2. Systemic lupus erythematosus (SLE)** | - Symmetrical polyarthritis (non-erosive)<br/>- Malar rash, photosensitivity, oral ulcers, alopecia<br/>- Fatigue, fever<br/>- Renal: proteinuria, hematuria                                                                |
| **3. Post-viral arthritis**               | - Recent viral prodrome or fever<br/>- Migratory polyarthralgia, myalgia<br/>- Rash (parvovirus → slapped cheek, hepatitis → jaundice)<br/>- Usually self-limiting                                                          |
| **4. Psoriatic arthritis**                | - Asymmetrical oligoarthritis or symmetrical polyarthritis<br/>- Dactylitis ("sausage digits"), nail pitting, onycholysis<br/>- Skin psoriasis lesions (scalp, extensor surfaces)                                           |
| **5. Reactive arthritis**                 | - Recent diarrhoea or urethritis (1–4 wks prior)<br/>- Asymmetrical oligoarthritis, usually lower limbs<br/>- Conjunctivitis, urethritis, mucocutaneous lesions ("can't see, can't pee, can't climb a tree")                |

## Investigations

### For Diagnosis & Differentiation

| Investigation      | RA                                   | SLE                                   | Post-viral arthritis        | Psoriatic arthritis            | Reactive arthritis |
| ------------------ | ------------------------------------ | ------------------------------------- | --------------------------- | ------------------------------ | ------------------ |
| **CBC**            | Normocytic anaemia, ↑ ESR            | Anaemia, leukopenia, thrombocytopenia | Normal or mild leukopenia   | Normocytic anaemia             | Mild leukocytosis  |
| **ESR / CRP**      | ↑↑                                   | ↑                                     | Mild ↑                      | ↑                              | ↑                  |
| **Autoantibodies** | RF+, anti-CCP+ (high specificity)    | ANA+, anti-dsDNA+, anti-Sm+           | Negative                    | RF– (usually), HLA-B27+        | HLA-B27+           |
| **Joint X-ray**    | Juxta-articular osteopenia, erosions | Usually normal                        | Normal                      | Pencil-in-cup deformity (late) | Normal early       |
| **Viral serology** | –                                    | –                                     | Positive for specific virus | –                              | –                  |
| **Urinalysis**     | –                                    | Proteinuria/haematuria                | –                           | –                              | –                  |

## Management for Each Diagnosis

import { Tabs } from "nextra/components";

<Tabs items={['RA', 'SLE', 'Post-viral', 'Psoriatic', 'Reactive']}>
<Tabs.Tab>

### General Principles

- **Early diagnosis and aggressive treatment** to prevent irreversible joint damage
- Treat-to-target approach aiming for **remission** or **low disease activity**
- Multidisciplinary care: rheumatologist, physiotherapist, occupational therapist, specialist nurse
- Patient education, lifestyle advice, vaccination review

### Pharmacological Management

#### A. First-line therapy (new diagnosis)

1. `MTX` 15 mg weekly + `Prednisolone` 30 mg daily

   - _DAS28 < 3.2_: Continue `MTX` alone
   - DAS28 ≥ 3.2: proceed to combination therapy

#### B. Combination DMARD therapy (if DAS28 ≥ 3.2)

1. Add `SSZ` and `HCQ` to `MTX`

   - _DAS28 < 3.2_: Continue `MTX` + `SSZ` + `HCQ`
   - DAS28 3.2 – 5.1: consider SC `MTX` or different `cDMARD`

     - _DAS28 < 3.2_: Continue therapy
     - DAS28 ≥ 3.2: proceed as DAS28 ≥ 5.1

   - DAS28 ≥ 5.1: Add biologic or `tsDMARD`

#### C. Biologic/targeted synthetic DMARDs

- Indicated if DAS28 remains ≥ 5.1 despite cDMARDs
- Examples: anti-TNF agents, IL-6 receptor antagonists, JAK inhibitors
- Monitor for infections, TB screening before initiation

#### D. Glucocorticoids

- Short-term bridging therapy during DMARD initiation
- Gradual taper to avoid long-term side effects

#### E. Symptomatic relief

- NSAIDs, analgesics for pain control
- PPIs for GI protection if NSAIDs used

### Non-Pharmacological Therapy

1. Physiotherapy
1. Occupational therapy
1. Psychologist support

### Surgery

1. Synovectomy
1. Joint arthroplasty
1. Metatarsalosteotomies, ulna head excisionwith wrist synovectomy
1. Upper cervical spine fixation
1. Joint fusion

</Tabs.Tab>

<Tabs.Tab>

### 1. General measures

- Education about disease and triggers (e.g., UV light, stress, infection)
- Sun protection (broad-spectrum sunscreen, protective clothing)
- Regular exercise, balanced diet
- Avoid smoking (reduces cardiovascular and renal risk)
- Vaccinations (pneumococcal, influenza, HPV) before starting immunosuppression

### 2. Drug therapy

#### A. Mild disease (skin, joints, mucosal involvement only)

- **`Hydroxychloroquine`** (HCQ) – cornerstone for all SLE patients unless contraindicated

  - Improves skin and joint symptoms, reduces flares, prevents organ damage
  - Dose: ≤5 mg/kg/day to reduce retinopathy risk
  - Eye examination at baseline and annually after 5 years

- **`NSAIDs`** – for arthritis, myalgia (short term, monitor renal and GI side effects)
- **`Low-dose corticosteroids`** (prednisolone ≤10 mg/day) – for flare control while other agents act

---

#### B. Moderate disease (serositis, mild-moderate hematologic or renal disease)

- **`Oral corticosteroids`** (prednisolone 10–30 mg/day, taper when possible)
- **`Azathioprine`** or **`Methotrexate`** – steroid-sparing agents
- **`Mycophenolate mofetil`** – for moderate nephritis or if azathioprine intolerant

#### C. Severe / organ-threatening disease (lupus nephritis, CNS lupus, severe hematologic disease)

- **Induction therapy**:

  - **`High-dose corticosteroids`** (IV methylprednisolone pulses 500–1000 mg/day × 3 days) → taper to oral
  - Plus **`Cyclophosphamide`** (low-dose Euro-Lupus regimen or NIH regimen)
  - Or **`Mycophenolate mofetil`** (alternative to cyclophosphamide in many cases)

- **Maintenance therapy**:

  - **`Azathioprine`** or **`Mycophenolate mofetil`**

- **Biologics**:

  - **`Belimumab`** (anti-BLyS) – for persistent active disease despite standard therapy
  - **`Rituximab`** – off-label for refractory severe SLE

#### D. Antiphospholipid syndrome (APS) in SLE

- **`Warfarin`** (target INR 2–3) for thrombotic APS
- **`Low-dose aspirin`** for asymptomatic high-risk patients
- In pregnancy: **`Heparin`** + low-dose aspirin

#### E. Special situations

- Pregnancy:

  - Continue **`Hydroxychloroquine`**
  - Use **`Azathioprine`** if immunosuppression needed (max 2 mg/kg/day)
  - Avoid mycophenolate, methotrexate, cyclophosphamide

- Vaccination: avoid live vaccines during immunosuppression

</Tabs.Tab>

<Tabs.Tab>

- Symptomatic treatment: `NSAIDs`, rest, hydration
- Usually resolves within 6–8 weeks
- _No role for long-term `DMARDs_` unless autoimmune triggered

</Tabs.Tab>

<Tabs.Tab>

- `NSAIDs` for pain
- `DMARDs` (`methotrexate`, `sulfasalazine`, `leflunomide`) for joint disease
- `Biologics` (anti-TNF) if severe/refractory
- Topical `steroids`, `vitamin D` analogues for skin lesions

</Tabs.Tab>

<Tabs.Tab>

- `NSAIDs` for pain/swelling
- Treat underlying infection (e.g., `doxycycline` for chlamydia)
- Short course `corticosteroids` if severe inflammation
- `DMARDs` (`sulfasalazine`, `methotrexate`) for persistent disease

</Tabs.Tab>

</Tabs>
